RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Rodrigo Vazquez Guillamet to Angiotensin-Converting Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications Rodrigo Vazquez Guillamet has written about Angiotensin-Converting Enzyme Inhibitors.
Rodrigo Vazquez Guillamet
Connection Strength
0.204
Angiotensin-Converting Enzyme Inhibitors
  1. January SE, Hubbard J, Fester KA, Dubrawka CA, Vazquez Guillamet R, Kulkarni HS, Hachem RR. Impact of Angiotensin Blockade on Development of Chronic Lung Allograft Dysfunction. J Pharm Pract. 2024 Oct; 37(5):1170-1174.
    View in: PubMed
    Score: 0.204
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support